Wealthfront Advisers »

Pacira Pharmaceuticals shares owned by Wealthfront Advisers

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Wealthfront Advisers from 13F filings

Historical chart of Wealthfront Advisers investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Wealthfront Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Wealthfront Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.0M 49k 20.62

More positions owned by Wealthfront Advisers

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Core Msci Emkt (IEMG)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Real Estate Etf (VNQ)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Extend Mkt Etf (VXF)

View all positions for Wealthfront Advisers

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Doma Perpetual Capital Management
Dimensional Fund Advisors
Renaissance Technologies
D. E. Shaw & Co
State Street Corporation
Balyasny Asset Management
American Century Companies
Goldman Sachs Group
Geode Capital Management
Morgan Stanley
UBS Group
J. Goldman & Co
Jacobs Levy Equity Management

View all funds holding Pacira Pharmaceuticals